Literature DB >> 22185449

The role of echocardiography in the management of the sources of embolism.

Roberta Esposito1, Rosa Raia, Daniela De Palma, Ciro Santoro, Maurizio Galderisi.   

Abstract

The echocardiographic diagnosis of cardiac thrombi, vegetations and tumors as well as the identification of predisposing conditions such as patent foramen ovale, aortic atherosclerosis and other minor causes (e.g., mitral valve prolapse, mitral and aortic valve calcification) have crucial clinical relevance, affecting the choice of surgery and/or of pharmaceutical therapy in the setting of patients presenting embolism. The echocardiographic assessment helps not only for the retrospective diagnosis of sources of embolism but also for the prevention of events in asymptomatic patients. Echocardiography can also distinguish normal variants and artifacts from cardiac masses and tumors. Echocardiographic characterization/typology of cardiac sources of embolism is currently below par when compared with cardiac MRI, the current gold standard. Nevertheless, echocardiography remains the 'first-line' imaging tool, because of its low cost and the possibility to add easily available, functional and structural information at the patient's bedside.

Entities:  

Mesh:

Year:  2012        PMID: 22185449     DOI: 10.2217/fca.11.72

Source DB:  PubMed          Journal:  Future Cardiol        ISSN: 1479-6678


  2 in total

1.  3D transesophageal echocardiography assists in evaluating the morphology, function, and presence of thrombi of left atrial appendage in patients with atrial fibrillation.

Authors:  Bingqing Deng; Ruqiong Nie; Qiong Qiu; Yulin Wei; Yingmei Liu; Hanlu Lv; Shaoxin Zheng; Jingfeng Wang
Journal:  Ann Transl Med       Date:  2021-05

2.  Spontaneous echo contrast masking thrombus in giant left atrium of mitral stenosis-a dilemma in clinical diagnosis.

Authors:  Akm Monwarul Islam; Md Abdus Salam; Md Zahidus Sayeed; Md Golam Kibria
Journal:  Pak J Med Sci       Date:  2015 Sep-Oct       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.